"cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma
Clinical trial NCT06590844 · UNKNOWN
Trial details
- NCT number
- NCT06590844
- Sponsor
- Anhui Provincial Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2026-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.